The mTOR Inhibitor Rapamycin Suppresses DNA Double-Strand Break Repair

The role of RPA2 phosphorylation in homologous recombination in response to replication arrest

(2010) Wei Shi et al.   CARCINOGENESIS

Enhancing mTOR-targeted cancer therapy

(2009) Xuerong Wang et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Cellular radiosensitivity: How much better do we understand it?

(2009) Penny Jeggo et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Homologous Recombination but Not Nucleotide Excision Repair Plays a Pivotal Role in Tolerance of DNA-Protein Cross-links in Mammalian Cells

(2009) Toshiaki Nakano et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Quantitative Nuclear Proteomics Identifies mTOR Regulation of DNA Damage Response

(2009) Sricharan Bandhakavi et al.   MOLECULAR & CELLULAR PROTEOMICS

Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma

(2009) O. Ekshyyan et al.   MOLECULAR CANCER THERAPEUTICS

Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation

(2008) M. Wall et al.   BLOOD

Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations

(2008) J LOPICCOLO et al.   DRUG RESISTANCE UPDATES

The homologous recombination system of Ustilago maydis

(2008) William K. Holloman et al.   FUNGAL GENETICS AND BIOLOGY

Disassembly of MDC1 Foci Is Controlled by Ubiquitin-Proteasome-dependent Degradation

(2008) Wei Shi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

 -H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin

(2008) A. Kinner et al.   NUCLEIC ACIDS RESEARCH